SIG North Trading, ULC

Position in TLRY — Tilray Brands, Inc.

CIK 1868643 Bala Cynwyd, PA

Back to TLRY Full portfolio

Position in TLRY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$464,203

+$35,486 QoQ

Shares Held

71,747

+51.1% QoQ

Ownership

0.062%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Derivatives in TLRY

reported options exposure · as of Mar 31, 2026

CallValue

$750,325

CallShares

115,970

PutValue

$271,740

PutShares

42,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

SIG North Trading, ULC holds $1,338,250 across 4 Drug Manufacturers - Specialty & Generic names. TLRY ranks #1 (34.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TLRY	Tilray Brands, Inc. This page	71,747	$464,203
2	CGC	Canopy Growth Corp	465,493	$441,752
3	CRON	Cronos Group Inc.	117,468	$294,844
4	ACB	Aurora Cannabis Inc	42,034	$137,451

All Filings in TLRY

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$464,203	71,747	+70.8%	Shares	Sole	2026-05-15
2026-03-31	$271,740	42,000	-63.8%	Put	Sole	2026-05-15
2026-03-31	$750,325	115,970	+45.3%	Call	Sole	2026-05-15
2025-12-31	$720,503	79,790	+187.2%	Call	Sole	2026-02-17
2025-12-31	$250,853	27,780	-41.5%	Put	Sole	2026-02-17
2025-12-31	$428,717	47,477	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.